Lewy body dementia: The caregiver experience of clinical care by Galvin, James E. et al.
LEWY BODY DEMENTIA: THE CAREGIVER EXPERIENCE OF
CLINICAL CARE
James E. Galvin, MD, MPH1, John E. Duda, MD2, Daniel I. Kaufer, MD3, Carol F. Lippa,
MD4, Angela Taylor5, and Steven H. Zarit, PhD6
1 Department of Neurology, New York University Langone School of Medicine, New York, NY
2 PADRECC, Philadelphia VA Medical Center and Department of Neurology, University of
Pennsylvania, Philadelphia, PA
3 Department of Neurology, University of North Carolina, Chapel Hill, NC
4 Department of Neurology, Drexel University College of Medicine, Philadelphia, PA
5 Lewy Body Dementia Association, Atlanta, GA
6 Department of Psychology, Pennsylvania State University, University Park, PA
Abstract
BACKGROUND—Lewy body dementia (LBD) is the second most common cause of dementia,
however, little is known about how the clinical diagnosis of LBD is obtained in the community or
the caregiver experience while seeking the diagnosis.
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METHODS—The Lewy Body Dementia Association (www.LBDA.org) conducted a web-based
survey of 962 caregivers over a 6-month period.
RESULTS—The mean age of respondents was 55.9y; 88% were female and 64% had daily
contact with patients. The mean age of LBD patients was 75.4y; 62% were male and 46% lived
with a caregiver. The most common presentation of symptoms as reported by LBD caregivers was
cognitive (48%), motor (39%) or both (13%). The first diagnoses given to the patients were
Parkinson disease or other movement disorder (39%), Alzheimer disease or other cognitive
disorder (36%), or mental illness (24%). Fifty percent of patients saw >3 doctors for more than 10
visits over the course of 1 year before an LBD diagnosis was established. Neurologists diagnosed
most cases (62%), while primary care-providers diagnosed only 6% of cases. No differences were
found between the presentation of disease and the number of physicians, number of office visits,
length of time to establish diagnosis, or type of doctor who finally made an LBD diagnosis.
Caregivers viewed physicians as knowledgeable about disease manifestations and treatment
options, but not about disease course/prognosis and available community resources and referrals.
CONCLUSIONS—These data highlight a need for increasing physician awareness and
knowledge of LBD, which will facilitate accurate diagnosis and treatment. Community resources
such as the Lewy Body Dementia Association may serve this end, while also providing practical
information and support for caregivers.
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INTRODUCTION
The Lewy body dementias (LBD) are the second most common cause of dementia after
Alzheimer disease (AD) affecting approximately 1.5 million Americans [1]. LBD includes
dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) – both
syndromes share many clinical and cognitive features [2]. It may be clinically impossible to
determine retrospectively, the precise onset of motor or cognitive symptoms sufficient to
make an initial diagnosis of Parkinsonism alone, dementia alone or a combined
Parkinsonism-dementia syndrome. In addition, there is no clinical or cognitive symptom that
absolutely distinguishes DLB and PDD as both may display psychiatric symptoms,
autonomic symptoms, rapid eye movement (REM) sleep behavior disorder, fluctuations in
cognition, sensitivity to neuroleptics and abnormalities in attention, executive function,
visuospatial abilities, memory and behavior [2]. Thus, LBD may be a more useful term to
capture a common phenotype in the community and is used in the present report to
encompass both DLB and PD dementia [1,2]. Consensus criteria have been published for
both DLB [3] and PDD [4]. While these criteria have good specificity, they are limited by
poor sensitivity [5,6]. Questions remain as to how well LBD is diagnosed and managed in
communities without a large academic specialty clinic. In addition, little is known about the
caregiver-patient experience of receiving a diagnosis and obtaining referrals to community
services.
Because LBD shares clinical features with more widely recognized diseases such as the pure
dementia phenotype of AD and the pure motor phenotype of PD, and psychotic and
behavioral features similar to those seen in psychiatric disease, LBD is more likely to be
under-recognized and initially mis-diagnosed [7,8]. Whether this is due to difficulty
applying consensus criteria to patients not in research studies or to a lack of clinical
familiarity with LBD among community physicians is unknown. Regardless, LBD
caregivers face a number of challenges. Many patients with LBD have prominent difficulties
with motor function, which lead to significant disability [9]. A large proportion of patients
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have recurrent behavioral disturbances including: visual hallucinations, cognitive
fluctuations and sleep disorders. These problems impact the LBD caregivers’ subjective
burden [10] and the patient’s quality of life [11], and may present different challenges
compared with caregivers of patients with AD or PD.
The Lewy Body Dementia Association (www.LBDA.org) conducted a web-based survey of
962 self-reported LBD caregivers over a 6-month period to address issues of challenges,
burdens and frustrations facing LBD caregivers in obtaining a diagnoses and care for the
patient. This goal of the survey was to ascertain the experiences of LBD caregivers and
collect data to improve diagnosis and management of LBD.
METHODS
Survey Design
An internet-based survey was developed by the LBDA and placed on-line using Survey
Monkey (www.SurveyMonkey.com, Portland, OR) to explore caregiver perceptions of the
difficulty obtaining a diagnosis for the patient and their experience with their healthcare
providers. The survey was posted for six months on the LBDA website (www.LBDA.org)
and a copy may be found at http://www.lbda.org/go/LBDcaregiversurvey. An announcement
in the LBDA newsletter and an e-mail reminder 1 week prior to closing the survey was sent
to all people who subscribe to the Lewy Body Digest, LBDA’s free e-newsletter. The survey
took 15 minutes to complete and 83% of 962 respondents completed the entire survey. All
procedures met requirements of the Health Information Portability and Accessibility Act
(HIPAA) and were approved by the Institutional Review Board at Pennsylvania State
University.
Statistical analyses
Descriptive statistics were determined for the sample using SPSS v15.0 (SPSS Inc, Chicago,
IL). Continuous variables were compared using Student t-test or analysis of variance, while
categorical measures were compared using Chi-square test. Pearson correlation coefficients
were used to examine relationships between variables. Most respondents self-identified
themselves as LBD caregivers (n=962), the remainder identified themselves as LBD
patients. Only caregiver respondents were included in the analyses. A check of IP addresses
assured that respondents had only completed one survey.
RESULTS
Sample Characteristics
The mean age of caregiver respondents was 55.9 ± 12y; 88% were female, 41% were
spouses, 74% had a college education and 64% identified themselves as the primary
caregiver who had daily contact with the patient. Seventy nine percent of respondents were
current caregivers. Caregivers of patients who had died were asked to respond based on the
patients’ condition at the time of their death. The mean age of the LBD patients was 75.4 ±
8.4y, 62% were males and 68% were married. In cases of LBD patients who were married
but whose spouse was not the primary caregiver, this role was largely filled by a daughter.
Forty six percent of patients lived with the respondent while 33% resided in long-term care
facilities. Respondents who were primary caregivers were older (p<.001) and less educated
(p<.001). The most common presentation of disease as reported by LBD caregivers was
cognitive (48%) or motor (39%). The remainder (13%) presented with both cognitive and
motor symptoms. There was no difference in any caregiver or patient characteristics based
on type of symptom presentation. The most frequent symptoms first noted by caregivers and
reported to the physician are shown in Table 1.
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Caregiver Experience with Obtaining a LBD Diagnosis
LBD caregivers reported the time between the presentation of the patient’s first symptom
and completion of the survey was 6.6 ± 4y. Respondents reported that they frequently saw
multiple physicians over multiple visits in order to establish an LBD diagnosis, this
experience is shown in Table 2. Patients saw 3.3 ± 1.5 physicians regarding a variety of
symptoms before an LBD diagnosis was made; 68% reported that more than 3 doctors were
consulted, 15% saw more than 5 different physicians. The survey also asked how long it had
taken to establish the diagnosis of LBD. The mean number of office visits needed to arrive
at a diagnosis was 3.7 ± 1.9; 33% required more than 6 office visits. Nineteen percent of
patients were diagnosed within the first month and 51% were diagnosed within the first year.
However, it took more than 2 years from the start of symptoms for 31% to receive an LBD
diagnosis. No differences in time to diagnosis or number of office visits were found between
primary and secondary caregivers. Considering the group that initially presented with both
cognitive and motor symptoms (N=150) likely had LBD from the onset, analyses of
caregiver responses revealed equally long delays in diagnoses with 3.4 ± 1.5 doctors visited,
3.8 ± 1.9 office visits over a median period of 12–18 months to receive an LBD diagnosis.
We compared the caregiver experiences based on type of symptom presentation (motor,
cognitive or both). No differences were found between the presentation of disease and the
number of physicians, number of office visits, length of time to establish diagnosis, or type
of doctor who finally made an LBD diagnosis. No differences were detected between
current and former caregivers. Secondary caregivers, who were more likely to be daughters,
reported their family members were less likely to get an alternative diagnosis (p<.001) than
reported by the primary caregivers.
Caregivers were asked to report the first diagnosis given to the patient. The initial diagnosis
was a disorder other than LBD in 78% of cases. The most common first diagnoses were PD
or some other form of parkinsonism (39%) or AD (26%). Less commonly other dementing
illnesses were given as the first diagnosis: frontotemporal dementia (4%), vascular dementia
(5%), mild cognitive impairment (6%) or some unspecified dementia (12%). Primary
psychiatric diagnoses were first diagnosed in 24% cases: major depression (19%), bipolar
disorder (3%), or schizophrenia (2%). Because we polled caregivers about the diagnostic
experience and the obvious difficulty in retrospectively assigning correct diagnoses, we
compared the type of symptom first noted by the caregiver with the first diagnosis given by
the physician. The results are shown in Table 3. Caregivers reported that no diagnosis was
given in 22% of cases when the patients’ symptoms were first presented to a physician. An
LBD diagnosis was established by a neurologist in 62% of the cases, followed by
psychiatrists (9%), geriatricians (8%) and psychologists (8%). Primary care physicians made
6% of the LBD diagnoses, including family physicians (5%) and internal medicine doctors
(1%). If a specialist (neurologist, psychiatrist, geriatrician) was the first physician seen, then
LBD was more likely to be diagnosed based on the presentation of symptoms (F=5.2, p<.
001).
Experiences after the Diagnosis
After the diagnosis was established, only 47% of patients continued to see the diagnosing
physician. Once an LBD diagnosis was made, patients were referred back to internists and
family medicine physicians in 58% of cases. Half of the LBD patients were seeing 2 or more
clinicians for LBD-related problems (e.g. behavior, sleep disturbances, autonomic
insufficiency); 58% caregivers reported they had difficulties coordinating care among the
different clinicians. Difference were found between types of caregivers, with primary
caregivers having less difficulty coordinating care than secondary caregivers (p<.001).
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Caregiver Perceptions of Physician Knowledge
Overall, 70% of caregivers had found it difficult to find a physician who knew the criteria
for diagnosing LBD and 77% of caregivers reported that it was difficult to find a physician
who knew about treating LBD. Former caregivers reported greater difficulties than current
caregivers (p<.001). The LBD caregivers were asked to evaluate the diagnosing physicians’
knowledge of LBD symptoms, management, and ancillary services (Table 4). Caregivers
thought both diagnosing and treating physicians were generally knowledgeable about
individual disease symptoms and current treatment options. At the time of diagnosis,
specialists (neurologists, psychiatrists, geriatricians) were rated as more knowledgeable
about LBD diagnosis, symptoms, treatment options and answering questions than primary
providers (all p-values <.01). Regardless of specialty, caregivers reported that the ability of
the physicians to discuss prognosis and course of disease, provide additional sources of
information for patient and caregiver education or refer to community services was
inadequate. No differences were found between type of symptom presentation and caregiver
perception of physician knowledge.
DISCUSSION
Caregivers of patients with LBD are often frustrated by their experiences with physicians.
Obtaining a LBD diagnosis often required multiple visits to multiple physicians, causing
significant delay in initiation of therapy. Over 40% of caregivers reported that it took more
than 18 months to arrive at an LBD diagnosis from the time of the first visit to a physician,
regardless of the initial symptom presentation. Although LBD was eventually diagnosed,
caregivers reported that alternative diagnoses were given first in 78% of cases (39% PD or
related disorder, 36% AD or other cognitive disorder, 32% mental illness). This does not
necessarily imply misdiagnosis, as the symptoms of LBD can evolve over time. For
example, if a patient started out with parkinsonism and only later developed cognitive or
behavioral symptoms, LBD would not be considered by the first physician. Similarly, if a
patient started out with cognitive symptoms, AD could have been a reasonable diagnosis
until other core features became apparent. The purpose of this study was to gain an
understanding of the experience of the patient and the caregiver with their physicians.
However, if one considers the group that most likely presented with the LBD phenotype at
onset, diagnostic experiences do not differ from the entire sample. Once diagnosed, most
patients were managed by primary care-providers. While caregivers thought both diagnosing
and treating physicians were knowledgeable about individual disease symptoms and current
treatment options, most respondents reported their physicians lacked knowledge regarding
not only the course and prognosis of the disease but also any available community resources
or allied health referrals.
The importance of early diagnosis and treatment is supported by data suggesting LBD
patients may have better responses to cholinesterase inhibitors than AD patients [12,13].
Early diagnosis provides opportunities to minimize exposure to medications that may
aggravate symptoms or lead to potentially fatal conditions such as severe neuroleptic
sensitivity reactions [14]. It also allows one to look for other commonly occurring and
treatable disorders such as REM behavior disorder. Although prognosis varies among
individuals, LBD is often a more rapidly progressive disease than AD [15,16]. Early
diagnosis permits caregivers and families an opportunity for more timely therapeutic
intervention, time to plan for expected decline in cognition, function and behavior, and avail
themselves of community resources for information and support.
Several possible explanations exist as to why LBD caregivers perceived a delay in
establishing a diagnosis. First, there may be a limited awareness of the signs and symptoms
of LBD among doctors, particularly primary care physicians [7,17]. Second, the current
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consensus diagnostic criteria are somewhat lacking in sensitivity, thus limiting their
usefulness in general practice [5]. Third, mild symptoms that suggest LBD may not be
observed by a clinician during a brief office visit or may not be reported by the patient or
caregiver. This may be particularly true in patients with dramatic cognitive fluctuations who
may be seen by the physician during a ‘good time’. Fourth, early in the disease, it can be
difficult to diagnose LBD with any certainty, even for well-trained specialists, so that some
patients will receive a general diagnosis of dementia, until they present with more specific
signs or symptoms. Lastly, there are currently no laboratory tests or validated biomarkers to
confirm the clinical diagnosis of LBD.
Our findings are generally consistent with other reports of diagnostic patterns of other forms
of dementia in the community. While primary care providers are generally knowledgeable
about diagnosing and treating dementia, less clinical experience regarding epidemiology and
differential diagnoses may make them less likely to recognize diseases such as LBD. A
study of 127 general practitioners suggested that knowledge of local diagnostic and support
services is less than general knowledge of dementia [17]. Additionally, one third of general
practitioners expressed limited confidence in their diagnostic skills, while two-thirds lacked
confidence managing the behavioral problems and other complications of dementia [17].
Physicians may also be more comfortable with diagnosing dementia than with managing
ongoing issues, and with immediate medical and psychiatric problems rather long-term
psychosocial issues [18]. General practitioners perceived lack of time and lack of social
services support as the major obstacles to good quality care more often than they identified
their own unfamiliarity with current management or with local resources [17]. A recent
metanalysis has explored possible reasons for diagnostic error in primary care [19]. This
report suggests that less common disorders (i.e. LBD) are less likely to be recognized in
primary care settings, leading to an increased number of more common diagnoses (i.e. AD).
Specialists may be more likely to make uncommon diagnoses, which may reflect their
research interests [19]. Often common medical conditions (malignancies, myocardial
infarction, meningitis, and anemia) that occur frequently in the elderly are investigated first.
Common difficulties in establishing diagnoses included atypical or non-specific
presentations, conditions with very low prevalence, the presence of co-morbid illnesses and
perceptual features [19], which are all characteristic of LBD. The difficulties described in
community settings inform ways to improve the diagnosis of dementia in primary care by
focusing on the need for timely diagnosis, developing guidelines that are applicable to a
busy primary care setting, and identification of appropriate referral pathways and diagnostic
strategies [20].
Our study is not without limitations. Respondents were self-reported caregivers of LBD
patients. No independent observations or medical records were available to review symptom
history or verify diagnoses. No objective information about the severity of patients’
symptoms in relation to the time the patient was brought to medical attention was available.
From the spectrum of clinical, cognitive and behavioral symptoms reported for the patients,
the clinical picture at the time of survey completion suggest most patients were in the
moderate to severe stages of LBD; however the stage of disease at time of diagnosis was not
captured. The survey did not discriminate DLB from PDD diagnoses; evaluation of
symptom onset (motor, cognitive or both) did not reveal differences in caregiver experiences
based on initial symptom presentation. The reports of delay in diagnosis were based on
solely on recall of the caregivers. There is no way to confirm whether physicians did not
recognize LBD or if they considered LBD as a diagnosis but did not inform the caregivers as
has been reported in other studies [8]. Caregivers were asked the specialty of the physician
(e.g. neurologist, psychiatrist) but were not asked to specify if they were aware of any
subspecialty interest (e.g. movement disorders, cognitive disorders). It should be noted that
the purpose of this study was to assess caregiver perceptions of physician understanding of
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LDB rather than evaluate physician knowledge. Lastly, caregivers who completed the
Internet-based survey may not be representative of caregivers in general. Families who
subscribe to newsletters by disease focused organizations such as LBDA may be better
informed about the disease and may differ in other characteristics that we were unable to
assess.
With these caveats in mind, these data highlight the need to increase physicians’ knowledge
of LBD, which should lead to accurate diagnoses and appropriate treatment [21,22].
Physicians caring for older adults may need a greater awareness of the prevalence and
clinical presentations of LBD in order to make a timely diagnosis. They may also benefit
from increased awareness of regional and national support services and diagnostic tools that
can assist in arriving at a timely and correct diagnosis of LBD and other dementias.
Community resources such as the Lewy Body Dementia Association may help to serve this
end, while also providing practical information and support for caregivers. These findings
highlight caregiver perception of unmet needs from physicians for LBD patients and their
families/caregivers.
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Table 1
LBD Symptoms Most Frequently Reported by Caregivers to Physicians
Symptom N %
Cognitive
Memory Problems 631 66.9
Difficulties managing finances 347 36.8
Poor judgment 294 31.2
Difficulties managing medications 294 31.2
Difficulties doing other daily tasks 265 28.1
Motor/Physical
Shuffling or other walking problems 446 47.3
Difficulties driving 393 41.7
Hand tremors 362 38.4
Problems with vision 269 28.5
Slowness of movement 261 27.7
Falling 258 27.4
Speaking difficulties 250 26.5
Behavioral
Lapses in attention or alertness/Staring spells 411 43.6
Hallucinations 402 42.6
Depression 351 37.2
Personality change 293 31.1
Paranoid beliefs or accusations 259 27.5
Mood swings 213 22.6
Apathy 179 19.0
Sleep Disturbance
Excessive daytime sleepiness 355 37.6
Thrashing during sleep 299 31.7
Nightmares 262 27.8
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Table 2
LBD Caregivers Experience with Obtaining LBD Diagnosis






More than 5 124 14.7
Time from 1st Visit to Diagnosis N %
First visit 77 9.3
Within one week 13 1.6
Within one month 69 8.3
Within three months 69 8.3
Within six months 97 11.7
Within twelve months 94 11.3
Between twelve and eighteen months 78 9.4
Between eighteen months and two years 74 8.9
Between two and three years 101 12.2
More than three years 159 19.1






6 or more 270 33.1
Specialty of Diagnosing Physician N %
Family Medicine 42 5.0
Geriatrician 69 8.3




Other medical specialty 30 3.6
Unsure of specialty 23 2.8
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Table 3
First Diagnosis Given to LBD Patients Based on Initial Symptom Presentation
Type of Symptom Presentation (%)
First Diagnoses Motor Cognitive Both
No diagnosis given 19.1 23.5 21.8
AD 9.2 19.2 8.8
FTD 0.7 5.4 1.2
MCI 1.4 1.6 1.2
VaD 3.2 3.8 5.3
Unspecified “dementia” 3.2 4.0. 6.5
PD 38.5 8.0 18.2
AD + PD 4.6 7.3 9.4
PD + MCI 3.2 2.6 2.4
AD + Depression 1.4 5.9 2.4
PD + Depression 6.4 4.7 6.5
Depression 4.6 7.5 7.6
Bipolar disorder 0.4 2.1 0.6
Schizophrenia 0.4 1.2 0.6
Other 3.9 3.1 7.6
Key: AD = Alzheimer disease, FTD = Frontotemporal dementia, MCI = mild cognitive impairment, VaD = Vascular dementia, PD = Parkinson
disease
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